Johns Hopkins 21st Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases 2025

• Target Audience: rheumatologists, internists, primary care physicians
• Sample video: contact me for sample video
• Information:

Target Audience Specialties – Rheumatology

Overview

Now in its 21st year, this two-day symposium has been planned for the providers who care for patients with rheumatic disease. Given the wide variety of rheumatologic disorders, and an ever increasing number of diagnostic procedures and treatment options, it is necessary to provide clinicians with information about strategies for the early diagnosis of these conditions, novel state-of-the-art diagnostic tools, and opportunities to utilize the most effective treatments to ensure optimal patient outcomes.

Objectives

Identify new treatment strategies in lupus nephritis.

Describe screening metrics for steroid induced osteoporosis and outline potential treatment paradigms.

Recognize the different subtypes of juvenile idiopathic arthritis (JIA).

Characterize new drugs for pulmonary hypertension in autoimmune disease.

Distinguish new and novel treatments for psoriatic arthritis.

The Johns Hopkins 21st Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases 2025 is best for clinicians—especially rheumatologists, internists, primary care physicians, nurse practitioners, physician assistants, and allied health professionals—who manage patients with rheumatic and autoimmune disorders and want the latest evidence-based updates.

Who Should Attend

Rheumatologists and internists seeking updates on diagnostic tools and treatment strategies

Primary care physicians who frequently encounter musculoskeletal and autoimmune conditions

Nurse practitioners, physician assistants, and allied health professionals involved in patient care and disease management

Residents, fellows, and trainees preparing for board exams or expanding their clinical knowledge

Researchers and educators interested in advances in rheumatology and translational science

What You’ll Learn

Early diagnosis strategies for complex autoimmune and inflammatory conditions

Updates on novel diagnostic procedures and imaging tools

Advances in biologic therapies, immunomodulators, and precision medicine

Management of systemic lupus erythematosus, rheumatoid arthritis, vasculitis, spondyloarthropathies, and other rheumatic diseases

Case-based discussions to improve clinical decision-making and patient outcomes

• Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

Friday, September 12, 2025

Saturday, September 13, 2025